Risk factors for various causes of failure in initial corneal grafts

被引:167
作者
Price, MO
Thompson, RW
Price, FW
机构
[1] Corneal Consultants Indiana, Indianapolis, IN 46260 USA
[2] Cornea Res Fdn Amer, Indianapolis, IN USA
[3] Kansas City Eye Clin, Overland Pk, KS USA
关键词
D O I
10.1001/archopht.121.8.1087
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To determine the risk factors for specific causes of initial corneal graft failure. Methods: This study analyzed corneal graft survival rates in a longitudinal noncomparative case series of 3992 consecutive penetrating keratoplasties performed at a single large referral center. Regrafts (n = 352) were excluded from the analysis of risk factors for initial graft failure. Data were collected retrospectively from August 1, 1982, through December 31, 1986, and prospectively from January 1, 1987, through August 31, 1996. Patients were examined preoperatively, at 1, 3, 6, 9, 12, 18, and 24 months posttransplantation, and annually thereafter. Potential risk factors were evaluated individually by Kaplan-Meier survival analysis. Cox proportional hazards regression modeling was then used to investigate the impact of each independent variable, adjusted for the confounding influence of the other independent variables. Results: The use of topical glaucoma medications was a significant risk factor for corneal graft failure by 3 major causes: rejection, endothelial decompensation without a documented immunologic reaction, and ocular surface disease. Deep stromal vascularization was an independent risk factor for rejection failure. Diabetes mellitus, peripheral anterior synechiae, recipient race, and small trephination size were significant risk factors for endothelial failure. Conclusion: Independent risk factors differentially impact specific causes of corneal graft failure.
引用
收藏
页码:1087 / 1092
页数:6
相关论文
共 34 条
[1]  
Arentsen J J, 1983, Trans Am Ophthalmol Soc, V81, P361
[2]  
Barraquer R I, 1989, Dev Ophthalmol, V18, P165
[3]  
Baudouin C, 1996, Curr Opin Ophthalmol, V7, P80, DOI 10.1097/00055735-199604000-00014
[4]   Ocular surface inflammatory changes induced by topical antiglaucoma drugs -: Human and animal studies [J].
Baudouin, C ;
Pisella, PJ ;
Fillacier, K ;
Goldschild, M ;
Becquet, F ;
De Saint Jean, M ;
Béchetoille, A .
OPHTHALMOLOGY, 1999, 106 (03) :556-563
[5]   Is donor age an important determinant of graft survival? [J].
Beck, RW ;
Gal, RL ;
Mannis, MJ ;
Holland, EJ ;
Cavanagh, HD ;
Foulks, GN ;
Heck, EL ;
Lindquist, T ;
Macsai, MS ;
Smith, RE ;
Stark, WJ ;
Stulting, RD ;
Sugar, J .
CORNEA, 1999, 18 (05) :503-510
[6]  
BEEBE WE, 1990, OPHTHALMOLOGY, V97, P1414
[7]   EFFECT OF FACTORS UNRELATED TO TISSUE MATCHING ON CORNEAL TRANSPLANT ENDOTHELIAL REJECTION [J].
BOISJOLY, HM ;
BERNARD, PM ;
DUBE, I ;
LAUGHREA, PA ;
BAZIN, R ;
BERNIER, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1989, 107 (06) :647-654
[8]  
BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728
[9]   CORNEAL CYTO-TOXICITY OF TOPICALLY APPLIED DRUGS, VEHICLES AND PRESERVATIVES [J].
BURSTEIN, NL .
SURVEY OF OPHTHALMOLOGY, 1980, 25 (01) :15-30
[10]   Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management [J].
Cantor, LB .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (04) :721-731